Product References
The expression of nicotinic acetylcholine receptor subunits and their associations with local immune cells and prognosis in oral squamous cell carcinoma.
Cancer medicine
Lin CM,Lin LW,Chen TC,Ye YL,Chiang BL
Published figure using CD44 monoclonal antibody (Product # MA5-13890) in Immunohistochemistry (Paraffin)
Fri Sep 01 00:00:00 EDT 2023
Complement protein C1q stimulates hyaluronic acid degradation via gC1qR/HABP1/p32 in malignant pleural mesothelioma.
Frontiers in immunology
Balduit A,Vidergar R,Zacchi P,Mangogna A,Agostinis C,Grandolfo M,Bottin C,Salton F,Confalonieri P,Rocca A,Zanconati F,Confalonieri M,Kishore U,Ghebrehiwet B,Bulla R
MA5-13890 was used in Western Blotting and Flow Cytometry to support the notion of an overall tumor-promoting property of C1q.
Tue Jun 20 00:00:00 EDT 2023
Complement protein C1q stimulates hyaluronic acid degradation via gC1qR/HABP1/p32 in malignant pleural mesothelioma.
Frontiers in immunology
Balduit A,Vidergar R,Zacchi P,Mangogna A,Agostinis C,Grandolfo M,Bottin C,Salton F,Confalonieri P,Rocca A,Zanconati F,Confalonieri M,Kishore U,Ghebrehiwet B,Bulla R
MA5-13890 was used in Western Blotting and Flow Cytometry to support the notion of an overall tumor-promoting property of C1q.
Tue Jun 20 00:00:00 EDT 2023
Complement protein C1q stimulates hyaluronic acid degradation via gC1qR/HABP1/p32 in malignant pleural mesothelioma.
Frontiers in immunology
Balduit A,Vidergar R,Zacchi P,Mangogna A,Agostinis C,Grandolfo M,Bottin C,Salton F,Confalonieri P,Rocca A,Zanconati F,Confalonieri M,Kishore U,Ghebrehiwet B,Bulla R
MA5-13890 was used in Western Blotting and Flow Cytometry to support the notion of an overall tumor-promoting property of C1q.
Tue Jun 20 00:00:00 EDT 2023
Complement protein C1q stimulates hyaluronic acid degradation via gC1qR/HABP1/p32 in malignant pleural mesothelioma.
Frontiers in immunology
Balduit A,Vidergar R,Zacchi P,Mangogna A,Agostinis C,Grandolfo M,Bottin C,Salton F,Confalonieri P,Rocca A,Zanconati F,Confalonieri M,Kishore U,Ghebrehiwet B,Bulla R
MA5-13890 was used in Western Blotting and Flow Cytometry to support the notion of an overall tumor-promoting property of C1q.
Tue Jun 20 00:00:00 EDT 2023
Machine learning-assisted elucidation of CD81-CD44 interactions in promoting cancer stemness and extracellular vesicle integrity.
eLife
Ramos EK,Tsai CF,Jia Y,Cao Y,Manu M,Taftaf R,Hoffmann AD,El-Shennawy L,Gritsenko MA,Adorno-Cruz V,Schuster EJ,Scholten D,Patel D,Liu X,Patel P,Wray B,Zhang Y,Zhang S,Moore RJ,Mathews JV,Schipma MJ,Liu T,Tokars VL,Cristofanilli M,Shi T,Shen Y,Dashzeveg NK,Liu H
Published figure using CD44 monoclonal antibody (Product # MA5-13890) in Western Blot
Tue Oct 04 00:00:00 EDT 2022
An instantly fixable and self-adaptive scaffold for skull regeneration by autologous stem cell recruitment and angiogenesis.
Nature communications
Lu G,Xu Y,Liu Q,Chen M,Sun H,Wang P,Li X,Wang Y,Li X,Hui X,Luo E,Liu J,Jiang Q,Liang J,Fan Y,Sun Y,Zhang X
MA5-13890 was used in Immunohistochemistry to design an instantly fixable and self-adaptive scaffold by dopamine-modified hyaluronic acid chelating Ca2+ of the microhydroxyapatite surface and bonding type I collagen to highly simulate the natural bony matrix.
Fri May 06 00:00:00 EDT 2022
Quantification of Antibody Persistence for Cell Surface Protein Labeling.
Cellular and molecular bioengineering
Dempsey ME,Woodford-Berry O,Darling EM
MA5-13890 was used in Immunocytochemistry-immunoflourescence to develop an easily adoptable method for researchers to characterize antibody removal timelines for any cell-antibody combination, with the benefit of studying broad, hypothesized mechanisms of antibody removal.
Tue Jun 01 00:00:00 EDT 2021
Lack of CD44 overexpression and application of concurrent chemoradiotherapy with cisplatin independently indicate excellent prognosis in patients with HPV-positive oropharyngeal cancer.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Biesaga B,Kołodziej-Rzepa M,Janecka-Widła A,Słonina D,Halaszka K,Przewoźnik M,Mucha-Małecka A
MA5-13890 was used in Immunohistochemistry to show that in patients with HPV16-positive oropharyngeal cancer, lack of CD44 overexpression and application of CisPt-CRT were found to be positive prognostic factors.
Mon May 31 00:00:00 EDT 2021
The Human TOR Signaling Regulator Is the Key Indicator of Liver Cancer Patients' Overall Survival: TIPRL/LC3/CD133/CD44 as Potential Biomarkers for Early Liver Cancers.
Cancers
Jun SY,Yoon HR,Yoon JY,Jeon SJ,Lee JJ,Halder D,Kim JM,Kim NS
MA5-13890 was used in Immunohistochemistry to analyze the prognostic and diagnostic potentials of TIPRL/LC3/CD133/CD44/CD46 using the receiver-operating characteristic curve, a Kaplan-Meier and uni-/multi-Cox analyses.
Fri Jun 11 00:00:00 EDT 2021
Distinguishing Specific CXCL12 Isoforms on Their Angiogenesis and Vascular Permeability Promoting Properties.
Advanced healthcare materials
Chang CW,Seibel AJ,Avendano A,Cortes-Medina MG,Song JW
MA5-13890 was used in Inhibition Assays to demonstrate that differences in binding to extracellular HA help underlie CXCL12 isoform-specific responses toward directing angiogenesis.
Sat Feb 01 00:00:00 EST 2020
Filoviruses Infect Rhesus Macaque Synoviocytes in Vivo and Primary Human Synoviocytes in Vitro.
The American journal of pathology
Cooper TK,Logue J,Liu DX,Perry DL,Hart RJ,Hischak AMW,Bernbaum JG,Gerhardt DM,Rojas O,Bohannon JK,Hagen KR,Johnson RF,Crozier I,Jahrling PB,Hensley LE,Bennett RS
MA5-13890 was used in Immunohistochemistry to study the link between Ebola virus and arthralgia in post-Ebola virus disease syndrome in the Rhesus macaque model.
Tue Sep 01 00:00:00 EDT 2020
Extracellular Domains I and II of cell-surface glycoprotein CD44 mediate its trans-homophilic dimerization and tumor cluster aggregation.
The Journal of biological chemistry
Kawaguchi M,Dashzeveg N,Cao Y,Jia Y,Liu X,Shen Y,Liu H
MA5-13890 was used in Western Blotting to examine the biochemical properties of CD44 in homotypic tumor cell aggregation.
Fri Feb 28 00:00:00 EST 2020
Extracellular Domains I and II of cell-surface glycoprotein CD44 mediate its trans-homophilic dimerization and tumor cluster aggregation.
The Journal of biological chemistry
Kawaguchi M,Dashzeveg N,Cao Y,Jia Y,Liu X,Shen Y,Liu H
MA5-13890 was used in Western Blotting to examine the biochemical properties of CD44 in homotypic tumor cell aggregation.
Fri Feb 28 00:00:00 EST 2020
A Comprehensive Molecular and Clinical Analysis of the piRNA Pathway Genes in Ovarian Cancer.
Cancers
Lee E,Lokman NA,Oehler MK,Ricciardelli C,Grutzner F
MA5-13890 was used in Immunohistochemistry (Paraffin) to show a piRNA pathway genes have key roles in the development of malignant neoplasms.
Tue Dec 22 00:00:00 EST 2020
A Comprehensive Molecular and Clinical Analysis of the piRNA Pathway Genes in Ovarian Cancer.
Cancers
Lee E,Lokman NA,Oehler MK,Ricciardelli C,Grutzner F
MA5-13890 was used in Immunohistochemistry (Paraffin) to show a piRNA pathway genes have key roles in the development of malignant neoplasms.
Tue Dec 22 00:00:00 EST 2020
Hyaluronan concentration and molecular mass in psoriatic arthritis: biomarkers of disease severity, resistance to treatment, and outcome.
Scandinavian journal of rheumatology
Hellman U,Engström-Laurent A,Larsson A,Lindqvist U
MA5-13890 was used in Immunohistochemistry to study the relationship between hyaluronan in skin and the quantity of circulating hyaluronan, and psoriatic arthritis.
Mon Jul 01 00:00:00 EDT 2019
The Histone Demethylase LSD1/ΚDM1A Mediates Chemoresistance in Breast Cancer via Regulation of a Stem Cell Program.
Cancers
Verigos J,Karakaidos P,Kordias D,Papoudou-Bai A,Evangelou Z,Harissis HV,Klinakis A,Magklara A
Published figure using CD44 monoclonal antibody (Product # MA5-13890) in Flow Cytometry
Thu Oct 17 00:00:00 EDT 2019
The Histone Demethylase LSD1/ΚDM1A Mediates Chemoresistance in Breast Cancer via Regulation of a Stem Cell Program.
Cancers
Verigos J,Karakaidos P,Kordias D,Papoudou-Bai A,Evangelou Z,Harissis HV,Klinakis A,Magklara A
Published figure using CD44 monoclonal antibody (Product # MA5-13890) in Flow Cytometry
Thu Oct 17 00:00:00 EDT 2019
CDK5-dependent phosphorylation and nuclear translocation of TRIM59 promotes macroH2A1 ubiquitination and tumorigenicity.
Nature communications
Sang Y,Li Y,Zhang Y,Alvarez AA,Yu B,Zhang W,Hu B,Cheng SY,Feng H
Published figure using CD44 monoclonal antibody (Product # MA5-13890) in Immunohistochemistry
Thu Sep 05 00:00:00 EDT 2019
CDK5-dependent phosphorylation and nuclear translocation of TRIM59 promotes macroH2A1 ubiquitination and tumorigenicity.
Nature communications
Sang Y,Li Y,Zhang Y,Alvarez AA,Yu B,Zhang W,Hu B,Cheng SY,Feng H
Published figure using CD44 monoclonal antibody (Product # MA5-13890) in Immunohistochemistry
Thu Sep 05 00:00:00 EDT 2019
The Role of C-X-C Chemokine Receptor Type 4 (CXCR4) in Cell Adherence and Spheroid Formation of Human Ewing's Sarcoma Cells under Simulated Microgravity.
International journal of molecular sciences
Romswinkel A,Infanger M,Dietz C,Strube F,Kraus A
MA5-13890 was used in Western Blotting to studied the behavior of Ewing's Sarcoma cells of the line A673 under simulated microgravity.
Mon Dec 02 00:00:00 EST 2019
Inhibition of GSK3 and MEK induced cancer stem cell generation via the Wnt and MEK signaling pathways.
Oncology reports
Liao S,Gan L,Qin W,Liu C,Mei Z
Published figure using CD44 monoclonal antibody (Product # MA5-13890) in Flow Cytometry
Mon Oct 01 00:00:00 EDT 2018
Hyaluronan in vocal folds and false vocal folds in patients with recurrent respiratory papillomatosis.
Acta oto-laryngologica
Holm A,Hellman U,Laurent C,Laurell G,Nylander K,Olofsson K
MA5-13890 was used in Immunohistochemistry on paraffin embedded tissues to characterise and localise hyaluronan and its receptor in vocal folds and false vocal folds in recurrent respiratory papillomatosis.
Thu Nov 01 00:00:00 EDT 2018
Role of Corneal Stromal Cells on Epithelial Cell Function during Wound Healing.
International journal of molecular sciences
Kowtharapu BS,Murín R,Jünemann AGM,Stachs O
Published figure using CD44 monoclonal antibody (Product # MA5-13890) in Western Blot
Sun Feb 04 00:00:00 EST 2018
Soluble CD83 Inhibits T Cell Activation by Binding to the TLR4/MD-2 Complex on CD14+ Monocytes.
Journal of immunology (Baltimore, Md. : 1950)
Horvatinovich JM,Grogan EW,Norris M,Steinkasserer A,Lemos H,Mellor AL,Tcherepanova IY,Nicolette CA,DeBenedette MA
MA513890 was used in blocking or activating experiment to implicate myeloid differentiation factor-2 as the high-affinity soluble CD83 binding partner
Wed Mar 15 00:00:00 EDT 2017
REST is a crucial regulator for acquiring EMT-like and stemness phenotypes in hormone-refractory prostate cancer.
Scientific reports
Chang YT,Lin TP,Campbell M,Pan CC,Lee SH,Lee HC,Yang MH,Kung HJ,Chang PC
MA513890 was used in immunocytochemistry to find RE1 silencing transcription factor regulates epithelial-mesenchymal transition and neuroendecrin cell stemness acquisition in hormone-refractory prostate cancer
Fri Mar 03 00:00:00 EST 2017
REST is a crucial regulator for acquiring EMT-like and stemness phenotypes in hormone-refractory prostate cancer.
Scientific reports
Chang YT,Lin TP,Campbell M,Pan CC,Lee SH,Lee HC,Yang MH,Kung HJ,Chang PC
MA513890 was used in immunocytochemistry to find RE1 silencing transcription factor regulates epithelial-mesenchymal transition and neuroendecrin cell stemness acquisition in hormone-refractory prostate cancer
Fri Mar 03 00:00:00 EST 2017
REST is a crucial regulator for acquiring EMT-like and stemness phenotypes in hormone-refractory prostate cancer.
Scientific reports
Chang YT,Lin TP,Campbell M,Pan CC,Lee SH,Lee HC,Yang MH,Kung HJ,Chang PC
MA513890 was used in immunocytochemistry to find RE1 silencing transcription factor regulates epithelial-mesenchymal transition and neuroendecrin cell stemness acquisition in hormone-refractory prostate cancer
Fri Mar 03 00:00:00 EST 2017
Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer.
Nature
Shu S,Lin CY,He HH,Witwicki RM,Tabassum DP,Roberts JM,Janiszewska M,Huh SJ,Liang Y,Ryan J,Doherty E,Mohammed H,Guo H,Stover DG,Ekram MB,Brown J,D'Santos C,Krop IE,Dillon D,McKeown M,Ott C,Qi J,Ni M,Rao PK,Duarte M,Wu SY,Chiang CM,Anders L,Young RA,Winer E,Letai A,Barry WT,Carroll JS,Long H,Brown M,Liu XS,Meyer CA,Bradner JE,Polyak K
MA5-13890 was used in immunohistochemistry to study triple-negative breast cancer and BET bromodomain inhibitor response and resistance
Thu Jan 21 00:00:00 EST 2016
MIF allele-dependent regulation of the MIF coreceptor CD44 and role in rheumatoid arthritis.
Proceedings of the National Academy of Sciences of the United States of America
Yoo SA,Leng L,Kim BJ,Du X,Tilstam PV,Kim KH,Kong JS,Yoon HJ,Liu A,Wang T,Song Y,Sauler M,Bernhagen J,Ritchlin CT,Lee P,Cho CS,Kim WU,Bucala R
MA513890 was used in flow cytometry to explore how the CD74/CD44 MIF receptor contributes to rheumatoid arthritis
Tue Dec 06 00:00:00 EST 2016
Overexpression of Specific CD44 Isoforms Is Associated with Aggressive Cell Features in Acquired Endocrine Resistance.
Frontiers in oncology
Bellerby R,Smith C,Kyme S,Gee J,Günthert U,Green A,Rakha E,Barrett-Lee P,Hiscox S
MA513890 was used in immunocytochemistry and western blot to investigate the roles of CD44v3 and CD44v6 in endocrine-resistant breast cancer
Wed Jul 06 00:00:00 EDT 2016
Combination of Cancer Stem Cell Markers CD44 and CD24 Is Superior to ALDH1 as a Prognostic Indicator in Breast Cancer Patients with Distant Metastases.
PloS one
Horimoto Y,Arakawa A,Sasahara N,Tanabe M,Sai S,Himuro T,Saito M
Published figure using CD44 monoclonal antibody (Product # MA5-13890) in Immunohistochemistry
Tue Jun 20 00:00:00 EDT 2017
Expression of cell adhesion molecule CD44 in mucoepidermoid carcinoma and its association with the tumor behavior.
Head & face medicine
Binmadi N,Elsissi A,Elsissi N
MA5-13890 was used in immunohistochemistry to assess CD44 expression in different grades of mucoepidermoid carcinoma
Fri Jan 29 00:00:00 EST 2016
Increased chemoresistance via Snail-Raf kinase inhibitor protein signaling in colorectal cancer in response to a nicotine derivative.
Oncotarget
Lee TY,Liu CL,Chang YC,Nieh S,Lin YS,Jao SW,Chen SF,Liu TY
MA5-13890 was used in flow cytometry to characterize colonic cells treated with 4-methylnitrosamino-1-3-pyridyl-1-butanone
Tue Apr 26 00:00:00 EDT 2016
An epigenetically distinct breast cancer cell subpopulation promotes collective invasion.
The Journal of clinical investigation
Westcott JM,Prechtl AM,Maine EA,Dang TT,Esparza MA,Sun H,Zhou Y,Xie Y,Pearson GW
MA5-13890 was used in immunohistochemistry to study promotion of collective invasion by an epigenetically distinct breast cancer cell subpopulation
Fri May 01 00:00:00 EDT 2015
The clinicopathological and prognostic significance of CD24, CD44, CD133, ALDH1 expressions in invasive ductal carcinoma of the breast: CD44/CD24 expression in breast cancer.
Pathology, research and practice
Kapucuoğlu N,Bozkurt KK,Başpınar Ş,Koçer M,Eroğlu HE,Akdeniz R,Akçil M
MA5-13890 was used in immunohistochemistry to evaluate the expression of CD24, CD44, CD133 and ALDH1 in invasive ductal carcinoma of the breast
Thu Oct 01 00:00:00 EDT 2015
The pattern of CD44 and matrix metalloproteinase 9 expression is a useful predictor of ulcerative colitis-associated dysplasia and neoplasia.
Annals of diagnostic pathology
AbdElazeem MA,El-Sayed M
MA5-13890 was used in immunohistochemistry - paraffin section to examine CD44 and MMP-9 expression in different ulcerative colitis lesions
Tue Dec 01 00:00:00 EST 2015
Immunohistochemical expression of CD44 standard and E-cadherin in atypical leiomyoma and leiomyosarcoma of the uterus.
Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology
Kaygusuz EI
MA5-13890 was used in immunohistochemistry - paraffin section to assess the diagnostic role of CD44 and E-cadherin in atypical leiomyoma and leiomyosarcoma.
Wed Apr 01 00:00:00 EDT 2015
Tetraspanin CD9 determines invasiveness and tumorigenicity of human breast cancer cells.
Oncotarget
Rappa G,Green TM,Karbanová J,Corbeil D,Lorico A
Published figure using CD44 monoclonal antibody (Product # MA5-13890) in Immunofluorescence
Fri Apr 10 00:00:00 EDT 2015
Effects of hypoxia and its relationship with apoptosis, stem cells, and angiogenesis on the thymus of children with congenital heart defects: a morphological and immunohistochemical study.
International journal of clinical and experimental pathology
Ceyran AB,Şenol S,Güzelmeriç F,Tunçer E,Tongut A,Özbek B,Şavluk Ö,Aydın A,Ceyran H
Published figure using CD44 monoclonal antibody (Product # MA5-13890) in Immunohistochemistry
Tue Jun 14 00:00:00 EDT 2016
Tau and PTEN status as predictive markers for response to trastuzumab and paclitaxel in patients with HER2-positive breast cancer.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Koo DH,Lee HJ,Ahn JH,Yoon DH,Kim SB,Gong G,Son BH,Ahn SH,Jung KH
MA5-13890 was used in immunohistochemistry - paraffin section to identify biomarkers using HER2-positive advanced breast cancer samples from patients treated with trastuzumab and paclitaxel combination chemotherapy
Sat Aug 01 00:00:00 EDT 2015
Interleukin-6 and pro inflammatory status in the breast tumor microenvironment.
World journal of surgical oncology
Sanguinetti A,Santini D,Bonafè M,Taffurelli M,Avenia N
MA5-13890 was used in immunohistochemistry - paraffin section to study the breast tumor microenvironment and interleukin-6 and pro inflammatory status
Sat Mar 28 00:00:00 EDT 2015
Genetic and phenotypic diversity in breast tumor metastases.
Cancer research
Almendro V,Kim HJ,Cheng YK,Gönen M,Itzkovitz S,Argani P,van Oudenaarden A,Sukumar S,Michor F,Polyak K
MA5-13890 was used in immunohistochemistry to study the diversity of breast cancer metastases at the genetic and phenotypic levels
Sat Mar 01 00:00:00 EST 2014
MicroRNA-9 is associated with epithelial-mesenchymal transition, breast cancer stem cell phenotype, and tumor progression in breast cancer.
Breast cancer research and treatment
Gwak JM,Kim HJ,Kim EJ,Chung YR,Yun S,Seo AN,Lee HJ,Park SY
MA5-13890 was used in immunohistochemistry - paraffin section to study miR-9, and miR-155 expression in breast cancer and how their expression correlates with different features of breast cancer
Fri Aug 01 00:00:00 EDT 2014
Y-box-binding protein 1 (YB1) in breast carcinomas: relation to aggressive tumor phenotype and identification of patients at high risk for relapse.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Mylona E,Melissaris S,Giannopoulou I,Theohari I,Papadimitriou C,Keramopoulos A,Nakopoulou L
MA5-13890 was used in immunohistochemistry to study the prognostic and clinical value of the Y-box-binding protein-1 expression pattern in breast carcinoma patients
Sat Mar 01 00:00:00 EST 2014
CD44/CD24 as potential prognostic markers in node-positive invasive ductal breast cancer patients treated with adjuvant chemotherapy.
Journal of molecular histology
Adamczyk A,Niemiec JA,Ambicka A,Mucha-Małecka A,Mituś J,Ryś J
MA5-13890 was used in immunohistochemistry to study the prognostic and clinical significance of CD44/CD24 expression in node-positive invasive ductal breast cancer
Sat Feb 01 00:00:00 EST 2014
Isolation and characterization of cancer stem cells from high-grade serous ovarian carcinomas.
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
He QZ,Luo XZ,Wang K,Zhou Q,Ao H,Yang Y,Li SX,Li Y,Zhu HT,Duan T
MA5-13890 was used in flow cytometry to study high-grade serous ovarian carcinoma cancer stem cells
Mon Jul 18 00:00:00 EDT 2016
Histological and prognostic importance of CD44(+) /CD24(+) /EpCAM(+) expression in clinical pancreatic cancer.
Cancer science
Ohara Y,Oda T,Sugano M,Hashimoto S,Enomoto T,Yamada K,Akashi Y,Miyamoto R,Kobayashi A,Fukunaga K,Morishita Y,Ohkohchi N
MA5-13890 was used in immunohistochemistry to study the clinical significance of CD44(+)/CD24(+)/EpCAM(+) cells in pancreatic cancer
Thu Aug 01 00:00:00 EDT 2013
Triple negative breast tumors in African-American and Hispanic/Latina women are high in CD44+, low in CD24+, and have loss of PTEN.
PloS one
Wu Y,Sarkissyan M,Elshimali Y,Vadgama JV
MA5-13890 was used in immunohistochemistry to study the prevalence of the high CD44(+)/low CD24(+) coupled with PTEN loss phenotype of triple-nagative breast cancer of African-American and Hispanic/Latina women in an Amercican population
Wed May 28 00:00:00 EDT 2014
Identification of prognostic biomarkers for glioblastomas using protein expression profiling.
International journal of oncology
Jung Y,Joo KM,Seong DH,Choi YL,Kong DS,Kim Y,Kim MH,Jin J,Suh YL,Seol HJ,Shin CS,Lee JI,Kim JH,Song SY,Nam DH
MA5-13890 was used in immunohistochemistry - paraffin section to identify diagnostic and prognostic markers for glioblastoma
Sun Apr 01 00:00:00 EDT 2012
Epigenetic regulation of cancer stem cell genes in triple-negative breast cancer.
The American journal of pathology
Kagara N,Huynh KT,Kuo C,Okano H,Sim MS,Elashoff D,Chong K,Giuliano AE,Hoon DS
MA5-13890 was used in immunohistochemistry to study the regulation of cancer stem cell genes at the epigenetic level in triple-negative breast cancer
Sun Jul 01 00:00:00 EDT 2012
Immunohistochemical detection of breast cancer stem cells in hormone receptor-positive breast cancer and their role in response to endocrine therapy and clinical outcome.
Oncology
Hashimoto K,Shimizu C,Tsuda H,Saji S,Osaki A,Shigekawa T,Aogi K
MA5-13890 was used in immunohistochemistry to study the role of breast cancer stem cells in the response of hormone receptor-positive breast cancer to endocrine therapy
Thu Jun 21 00:00:00 EDT 2012
Neoadjuvant chemotherapy with gemcitabine for pancreatic cancer increases in situ expression of the apoptosis marker M30 and stem cell marker CD44.
Oncology letters
Tajima H,Ohta T,Kitagawa H,Okamoto K,Sakai S,Kinoshita J,Makino I,Furukawa H,Hayashi H,Nakamura K,Oyama K,Inokuchi M,Nakagawara H,Fujita H,Takamura H,Ninomiya I,Fushida S,Tani T,Fujimura T,Kitamura S,Ikeda H,Tsuneyama K
MA5-13890 was used in immunohistochemistry to study the increased expression of M30 and CD44 in resected pancreatic cancer samples following neoadjuvant chemotherapy with gemcitabine
Fri Jun 01 00:00:00 EDT 2012
CD44 is associated with tumor recurrence and is an independent poor prognostic factor for patients with localized clear cell renal cell carcinoma after nephrectomy.
Experimental and therapeutic medicine
Jeong BJ,Liang ZL,Huang SM,Lim JS,Kim JM,Lee HJ
MA5-13890 was used in immunohistochemistry to study the prognostic value of the immunohistochemical expression of CD44 in patients with localized clear cell renal cell carcinoma
Tue May 01 00:00:00 EDT 2012
The JAK2/STAT3 signaling pathway is required for growth of CD44⁺CD24⁻ stem cell-like breast cancer cells in human tumors.
The Journal of clinical investigation
Marotta LL,Almendro V,Marusyk A,Shipitsin M,Schemme J,Walker SR,Bloushtain-Qimron N,Kim JJ,Choudhury SA,Maruyama R,Wu Z,Gönen M,Mulvey LA,Bessarabova MO,Huh SJ,Silver SJ,Kim SY,Park SY,Lee HE,Anderson KS,Richardson AL,Nikolskaya T,Nikolsky Y,Liu XS,Root DE,Hahn WC,Frank DA,Polyak K
MA5-13890 was used in immunocytochemistry to identify treatment targets common to breast tumor subpopulations
Fri Jul 01 00:00:00 EDT 2011
An increase in cancer stem cell population after primary systemic therapy is a poor prognostic factor in breast cancer.
British journal of cancer
Lee HE,Kim JH,Kim YJ,Choi SY,Kim SW,Kang E,Chung IY,Kim IA,Kim EJ,Choi Y,Ryu HS,Park SY
MA5-13890 was used in immunohistochemistry to study the increase in cancer stem cell numbers after primary systemic therapy as a poor prognostic factor in breast cancer
Tue May 24 00:00:00 EDT 2011
A comprehensive characterization study of human bone marrow mscs with an emphasis on molecular and ultrastructural properties.
Journal of cellular physiology
Karaöz E,Okçu A,Gacar G,Sağlam O,Yürüker S,Kenar H
MA5-13890 was used in immunocytochemistry to study the molecular and ultrastructural properties of human bone marrow-derived mesenchymal stem cells
Sun May 01 00:00:00 EDT 2011
Expression of CD44 and MMP-2: possible association with histopathological features of pleuro-pulmonary solitary fibrous tumors.
Turk patoloji dergisi
Demırağ F,Cakir E,Alpar S,Taştepe I,Kaya S
MA5-13890 was used in immunohistochemistry to investigate the relationship between the level of CD44/MMP-2 and histopathological characteristics in solitary fibrous tumors
Sun May 01 00:00:00 EDT 2011
Role of versican, hyaluronan and CD44 in ovarian cancer metastasis.
International journal of molecular sciences
Ween MP,Oehler MK,Ricciardelli C
MA5-13890 was used in immunohistochemistry to study the role of versican, hyaluronan and CD44 in ovarian cancer metastasis
Mon Jan 31 00:00:00 EST 2011
Novel immunofluorescence protocol for multimarker assessment of putative disseminating breast cancer stem cells.
Applied immunohistochemistry & molecular morphology : AIMM
Balic M,Rapp N,Stanzer S,Lin H,Strutz J,Szkandera J,Daidone MG,Samonigg H,Cote RJ,Dandachi N
MA5-13890 was used in immunohistochemistry to investigate the efficiency of a new method for the assessment of putative disseminating breast cancer stem cells
Sat Jan 01 00:00:00 EST 2011
Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype.
The Journal of clinical investigation
Park SY,Gönen M,Kim HJ,Michor F,Polyak K
MA5-13890 was used in immunohistochemistry to identify the sources of genetic diversity in human breast tumors
Mon Feb 01 00:00:00 EST 2010
Simple karyotype and bcl-6 expression predict a diagnosis of Burkitt lymphoma and better survival in IG-MYC rearranged high-grade B-cell lymphomas.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Seegmiller AC,Garcia R,Huang R,Maleki A,Karandikar NJ,Chen W
MA5-13890 was used in immunohistochemistry to characterize the relationship between karyotype and lymphomas
Thu Jul 01 00:00:00 EDT 2010
Aggressive progression of breast cancer with microscopic pulmonary emboli possessing a stem cell-like phenotype independent of its origin.
Pathology international
Kawasaki H,Ogura H,Arai Y,Baba S,Kosugi I,Tsutsui Y,Iwashita T
MA5-13890 was used in immunohistochemistry to investigate the stem-like characteristics of microscopic pulmonary emboli
Mon Mar 01 00:00:00 EST 2010
Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers.
Clinical cancer research : an official journal of the American Association for Cancer Research
Tanei T,Morimoto K,Shimazu K,Kim SJ,Tanji Y,Taguchi T,Tamaki Y,Noguchi S
MA5-13890 was used in immunohistochemistry to study whether cancer stem cells are clinically significant for resistance to chemotherapy in human breast cancers
Mon Jun 15 00:00:00 EDT 2009
CD44-positive cells are responsible for gemcitabine resistance in pancreatic cancer cells.
International journal of cancer
Hong SP,Wen J,Bang S,Park S,Song SY
MA5-13890 was used in immunohistochemistry to study the role of CD44-positive cells in gemcitabine resistance in pancreatic cancer
Sun Nov 15 00:00:00 EST 2009
Identification of CD44v6(+)/CD24- breast carcinoma cells in primary human tumors by quantum dot-conjugated antibodies.
Laboratory investigation; a journal of technical methods and pathology
Snyder EL,Bailey D,Shipitsin M,Polyak K,Loda M
MA5-13890 was used in immunohistochemistry to identify CD44v6(+)/CD24- human breast carcinoma cells using quantum dot-conjugated antibodies
Sat Aug 01 00:00:00 EDT 2009
Plasmablastic lymphomas with MYC/IgH rearrangement: report of three cases and review of the literature.
American journal of clinical pathology
Bogusz AM,Seegmiller AC,Garcia R,Shang P,Ashfaq R,Chen W
MA5-13890 was used in immunohistochemistry to investigate the relationship between MYC/IgH rearrangements and plasmablastic lymphomas
Thu Oct 01 00:00:00 EDT 2009
Expression of CD44s in incidental prostate cancer is more strongly associated with Gleason scores on subsequent radical prostatectomies than conventional prognostic parameters.
Pathobiology : journal of immunopathology, molecular and cellular biology
Gunia S,May M,Koch S,Dietel M,Erbersdobler A
MA5-13890 was used in immunohistochemistry to study the prognostic significance of CD44s in incidental prostate cancer
Thu Feb 25 00:00:00 EST 2010
Rare steroid receptor-negative basal-like tumorigenic cells in luminal subtype human breast cancer xenografts.
Proceedings of the National Academy of Sciences of the United States of America
Horwitz KB,Dye WW,Harrell JC,Kabos P,Sartorius CA
MA5-13890 was used in immunohistochemistry to study rare steroid receptor-negative basal-like tumorigenic cells in luminal subtype human breast tumors
Tue Apr 15 00:00:00 EDT 2008
The CD44+/CD24- phenotype is enriched in basal-like breast tumors.
Breast cancer research : BCR
Honeth G,Bendahl PO,Ringnér M,Saal LH,Gruvberger-Saal SK,Lövgren K,Grabau D,Fernö M,Borg A,Hegardt C
Published figure using CD44 monoclonal antibody (Product # MA5-13890) in Immunohistochemistry
Wed Nov 12 00:00:00 EST 2008
The CD44+/CD24- phenotype is enriched in basal-like breast tumors.
Breast cancer research : BCR
Honeth G,Bendahl PO,Ringnér M,Saal LH,Gruvberger-Saal SK,Lövgren K,Grabau D,Fernö M,Borg A,Hegardt C
Published figure using CD44 monoclonal antibody (Product # MA5-13890) in Immunohistochemistry
Wed Nov 12 00:00:00 EST 2008
Periodontal tissue engineering by transplantation of multilayered sheets of phenotypically modified gingival fibroblasts.
Journal of periodontal research
Nakajima K,Abe T,Tanaka M,Hara Y
MA5-13890 was used in immunohistochemistry to develop and evaluate a novel fibronectin graft for periodontal tissue engineering
Mon Dec 01 00:00:00 EST 2008
The clinicopathologic and prognostic significance of CD44+/CD24(-/low) and CD44-/CD24+ tumor cells in invasive breast carcinomas.
Human pathology
Mylona E,Giannopoulou I,Fasomytakis E,Nomikos A,Magkou C,Bakarakos P,Nakopoulou L
MA5-13890 was used in immunohistochemistry to study the prognostic importance of CD44(+)/CD24(-/low) and CD44(-)/CD24(+) tumor phenotypes in invasive breast carcinoma
Tue Jul 01 00:00:00 EDT 2008
Cell-surface MMP-9 regulates the invasive capacity of leukemia blast cells with monocytic features.
Cell cycle (Georgetown, Tex.)
Paupert J,Mansat-De Mas V,Demur C,Salles B,Muller C
MA5-13890 was used in flow cytometry to study the role of cell surface MMP-9 in regulating the invasive capacity of leukemia blast cells
Tue Apr 15 00:00:00 EDT 2008
IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland.
The Journal of clinical investigation
Sansone P,Storci G,Tavolari S,Guarnieri T,Giovannini C,Taffurelli M,Ceccarelli C,Santini D,Paterini P,Marcu KB,Chieco P,Bonafè M
MA5-13890 was used in immunohistochemistry to study the role of IL-6 in triggering the development of malignant features in mammospheres
Sat Dec 01 00:00:00 EST 2007
Estrogen insensitivity in a model of estrogen receptor positive breast cancer lymph node metastasis.
Cancer research
Harrell JC,Dye WW,Harvell DM,Pinto M,Jedlicka P,Sartorius CA,Horwitz KB
MA5-13890 was used in immunohistochemistry to study the lack of estrogen-sensitivity of lymph node metastases in a model of estrogen receptor positive breast cancer
Thu Nov 01 00:00:00 EDT 2007
Moesin expression is a marker of basal breast carcinomas.
International journal of cancer
Charafe-Jauffret E,Monville F,Bertucci F,Esterni B,Ginestier C,Finetti P,Cervera N,Geneix J,Hassanein M,Rabayrol L,Sobol H,Taranger-Charpin C,Xerri L,Viens P,Birnbaum D,Jacquemier J
MA5-13890 was used in immunohistochemistry to study moesin expression as a marker of basal breast carcinoma
Mon Oct 15 00:00:00 EDT 2007
Formation of hyaluronan- and versican-rich pericellular matrix by prostate cancer cells promotes cell motility.
The Journal of biological chemistry
Ricciardelli C,Russell DL,Ween MP,Mayne K,Suwiwat S,Byers S,Marshall VR,Tilley WD,Horsfall DJ
MA5-13890 was used in immunocytochemistry to study the role of the pericellular matrix in promoting prostate cancer cell motility
Fri Apr 06 00:00:00 EDT 2007
Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype.
Clinical cancer research : an official journal of the American Association for Cancer Research
Balic M,Lin H,Young L,Hawes D,Giuliano A,McNamara G,Datar RH,Cote RJ
MA5-13890 was used in immunohistochemistry to characterize the early disseminated cancer cells in bone marrow of breast cancer patients
Sun Oct 01 00:00:00 EDT 2006
Estrogen receptor positive breast cancer metastasis: altered hormonal sensitivity and tumor aggressiveness in lymphatic vessels and lymph nodes.
Cancer research
Harrell JC,Dye WW,Allred DC,Jedlicka P,Spoelstra NS,Sartorius CA,Horwitz KB
MA5-13890 was used in immunohistochemistry to study the role of estrogen receptor in breast cancer metastasis
Fri Sep 15 00:00:00 EDT 2006
Downregulation of BRG-1 repressed expression of CD44s in cervical neuroendocrine carcinoma and adenocarcinoma.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Kuo KT,Liang CW,Hsiao CH,Lin CH,Chen CA,Sheu BC,Lin MC
MA5-13890 was used in immunohistochemistry to investigate the mechanism for CD44s regulation in cervical neuroendocrine carcinoma and adenocarcinoma
Fri Dec 01 00:00:00 EST 2006
Novel prognostic value of nuclear epidermal growth factor receptor in breast cancer.
Cancer research
Lo HW,Xia W,Wei Y,Ali-Seyed M,Huang SF,Hung MC
MA5-13890 was used in immunohistochemistry to study the prognostic value of nuclear-localized EGFR in beast cancer
Sat Jan 01 00:00:00 EST 2005
Loss of CD10 (neutral endopeptidase) is a frequent and early event in human prostate cancer.
The Prostate
Freedland SJ,Seligson DB,Liu AY,Pantuck AJ,Paik SH,Horvath S,Wieder JA,Zisman A,Nguyen D,Tso CL,Palotie AV,Belldegrun AS
MA5-13890 was used in immunohistochemistry to study the role of CD10 loss in the development of human prostate cancer
Tue Apr 01 00:00:00 EST 2003
